Gene · 8405
Papers2,215
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,215
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Association of ATM Alterations with Outcomes After 177Lu-PSMA-617 Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer. | J Nucl Med | 2026 | 42785951 | PubTator, text mining | PubMed |
| SPOP-mediated ZMYND8 ubiquitination and phase separation exclusion drives mTOR inhibitor resistance in kidney cancer. | Nat Commun | 2026 | 42778578 | PubTator, text mining | PubMed |
| Genomic and transcriptomic correlates of deep prostate-specific antigen response in patients with metastatic androgen pathway modulation-sensitive prostate cancer. | Oncologist | 2026 | 42752828 | PubTator, text mining | PubMed |
| Intratumoral Human Papillomavirus in Advanced Prostate Cancer: Systematic Review, Meta-Analysis, and Real-World Evidence from the Largest Cohort to Date. | Int J Mol Sci | 2026 | 42737728 | PubTator, text mining | PubMed |
| Erratum: The RNA helicase DDX17 enhances androgen receptor stability by interacting with the E3 ubiquitin ligase SPOP in prostate cancer. | Transl Androl Urol | 2026 | 42729183 | PubTator, text mining | PubMed |
| IL-23 promotes PD-L1 expression and tumor immune evasion via METTL16 pathway. | Am J Cancer Res | 2026 | 42724552 | PubTator, text mining | PubMed |
| Association between smoking, tumor genetics, and outcomes in men with metastatic prostate cancer. | Prostate Cancer Prostatic Dis | 2026 | 42697914 | PubTator, text mining | PubMed |
| Proteo-genomics-guided interpretation of somatic mutations in cancer genomes. | Cancer Cell | 2026 | 42628524 | PubTator, text mining | PubMed |
| Double donut versus filament: How structural shapes regulate SPOP activity and cancer pathogenesis. | Mol Cell | 2026 | 42561922 | PubTator, text mining | PubMed |
| Early-Onset Prostate Cancer: Epidemiology, Risk Factors, Biology, Clinical Features, Management, and Early Detection. | MedComm (2020) | 2026 | 42488705 | PubTator, text mining | PubMed |
| Interference of clonal hematopoiesis in cfDNA liquid biopsy testing and identification of actionable alterations in large diverse cohort of US veterans. | Oncologist | 2026 | 42479142 | PubTator, text mining | PubMed |
| Long-read, whole-genome sequencing and chemotherapy response of two patient-derived organoids from a TP53- and KRAS-mutant ovarian carcinoma. | bioRxiv | 2026 | 42465424 | PubTator, text mining | PubMed |
| Large-scale quaternary structural transitions underlie gain of function of SPOP cancer mutations. | Mol Cell | 2026 | 42442353 | PubTator, text mining | PubMed |
| Divergent roles of SPOP and CHD1 in ACSL4 regulation reveal context-dependent vulnerabilities for targeting ferroptosis. | Nat Commun | 2026 | 42380152 | PubTator, text mining | PubMed |
| Predictive biomarkers of response in metastatic prostate cancer: paving the way for a new era of precision medicine. | Expert Rev Anticancer Ther | 2026 | 42376796 | PubTator, text mining | PubMed |
| Prostate Cancer: Etiology, Diagnosis, and Treatment. | Serican J Med | 2026 | 42375929 | PubTator, text mining | PubMed |
| The APC/C adaptor Cdh1 stabilizes STING to potentiate innate immune activation in renal cell carcinoma. | Sci Signal | 2026 | 42335217 | PubTator, text mining | PubMed |
| SPOP-mediated nuclear ubiquitination degradation of p62/SQSTM1 contributes to HR repair. | Oncogene | 2026 | 42323478 | PubTator, text mining | PubMed |
| High-throughput screening identifies a critical role of the SPOP-PABPC1 axis in lung adenocarcinoma progression. | Proc Natl Acad Sci U S A | 2026 | 42268896 | PubTator, text mining | PubMed |
| MYC contributes to targeted therapy resistance in lung cancers driven by MET exon 14-skipping alteration. | NPJ Precis Oncol | 2026 | 42162296 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8405/papers